INDUSTRY NEWS: Remix Therapeutics reports encouraging clinical progress for its MYB mRNA degrader REM-422 - Meet Them In November
INDUSTRY NEWS: Evotec announces a recent CRYO-EM breakthrough using structural biology - Explore These New Approaches in November
EXCITING: Skyhawk have recently booked a group to attend this year's conference - View Attending Companies List
EXCITING: PTC are bringing 16 people to the conference! - Register to Meet Them in November
NEW SPEAKER: Ribometrix's CSO is joining the Pre-Conference Workshop Day Speaker Line-Up - Register to Join Them

Chair’s Closing Remarks

Chair’s Closing Remarks

4:15 pm - Thursday 12th November 2026

Speakers:

Dominic Reynolds

Dominic Reynolds

Chief Scientific Officer

Remix Therapeutics